April 29, 2020 / 9:20 AM / a month ago

BRIEF-Hubei Biocause Pharmaceutical's Q1 Net Profit Up 16.7% Y/Y

April 29 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd :

* SAYS Q1 NET PROFIT UP 16.7% Y/Y AT 384.3 MILLION YUAN ($54.33 million) Source text in Chinese: bit.ly/2VLw2DT Further company coverage: ($1 = 7.0737 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below